ES2162862T3 - Uso de la timosina para tratar la hepatitis c en pacientes que no responden al tratamiento con interferon. - Google Patents

Uso de la timosina para tratar la hepatitis c en pacientes que no responden al tratamiento con interferon.

Info

Publication number
ES2162862T3
ES2162862T3 ES94910226T ES94910226T ES2162862T3 ES 2162862 T3 ES2162862 T3 ES 2162862T3 ES 94910226 T ES94910226 T ES 94910226T ES 94910226 T ES94910226 T ES 94910226T ES 2162862 T3 ES2162862 T3 ES 2162862T3
Authority
ES
Spain
Prior art keywords
treatment
timosine
interfer
respond
patients
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94910226T
Other languages
English (en)
Inventor
Paul B Chretien
Milton Mutchnick
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wayne State University
Alpha 1 Biomedicals Inc
Original Assignee
Wayne State University
Alpha 1 Biomedicals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/027,500 external-priority patent/US6001799A/en
Application filed by Wayne State University, Alpha 1 Biomedicals Inc filed Critical Wayne State University
Application granted granted Critical
Publication of ES2162862T3 publication Critical patent/ES2162862T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2292—Thymosin; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Abstract

UN METODO PARA EL TRATAMIENTO DE HEPATITIS C ADMINISTRANDO UNA DOSIS DE PTENCIACION DEL SISTEMA INMUNOLOGICO DE AL MENOS UN TIMOSIN O UN FRAGMENTO DE TIMOSIN QUE POTENCIA EL SISTEMA A UN MAMIFERO INFECTADO CON EL VIRUS DE HEPATITIS C, CUYA INFECCION EN EL MAMIFERO NO RESPONDE AL TRATAMIENTO SOLAMENTE CON INTERFERON.
ES94910226T 1993-03-05 1994-03-03 Uso de la timosina para tratar la hepatitis c en pacientes que no responden al tratamiento con interferon. Expired - Lifetime ES2162862T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/027,500 US6001799A (en) 1991-09-13 1993-03-05 Method of treating hepatitis C in non-responders to interferon treatment

Publications (1)

Publication Number Publication Date
ES2162862T3 true ES2162862T3 (es) 2002-01-16

Family

ID=21838079

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94910226T Expired - Lifetime ES2162862T3 (es) 1993-03-05 1994-03-03 Uso de la timosina para tratar la hepatitis c en pacientes que no responden al tratamiento con interferon.

Country Status (17)

Country Link
EP (1) EP0687181B1 (es)
JP (1) JPH06279309A (es)
KR (1) KR100306024B1 (es)
CN (1) CN1072961C (es)
AT (1) ATE204760T1 (es)
AU (1) AU683248B2 (es)
CA (1) CA2157479C (es)
DE (1) DE69428112T2 (es)
DK (1) DK0687181T3 (es)
ES (1) ES2162862T3 (es)
FI (1) FI954127A (es)
GR (1) GR3037021T3 (es)
MY (1) MY121198A (es)
NO (1) NO320877B1 (es)
PT (1) PT687181E (es)
SG (1) SG64894A1 (es)
WO (1) WO1994020131A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000507917A (ja) 1995-11-02 2000-06-27 シェーリング コーポレイション 持続的低用量サイトカイン注入治療
US7208167B2 (en) 2000-08-07 2007-04-24 Sciclone Pharmaceuticals, Inc. Treatment of hepatitis C with thymosin and peptide combination therapy
AU2001287160B2 (en) * 2000-08-07 2005-08-18 Sciclone Pharmaceuticals, Inc. Treatment of Hepatitis C with Thymosin and Pegylated interferon
EP1613340B1 (en) 2003-03-28 2010-05-12 SciClone Pharmaceuticals, Inc. Treatment of aspergillus infections with thymosin alpha 1
ES2389452T3 (es) * 2006-05-02 2012-10-26 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Uso de timosina 1, sola o en combinación con PTX3 o ganciclovir, para el tratamiento de infección por citomegalovirus
WO2010122538A1 (en) * 2009-04-24 2010-10-28 Santaris Pharma A/S Pharmaceutical compositions for treatment of hcv patients that are non-responders to interferon
JP2012526149A (ja) 2009-05-08 2012-10-25 サイクローン・ファーマシューティカルズ・インコーポレイテッド ワクチン増強剤としてのαチモシンペプチド

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1216056B (it) * 1988-03-11 1990-02-22 Sclavo Spa Composizioni farmaceutiche contenenti timosina alfa 1.
TW224053B (es) * 1991-09-13 1994-05-21 Paul B Chretien

Also Published As

Publication number Publication date
DE69428112D1 (de) 2001-10-04
CN1072961C (zh) 2001-10-17
AU683248B2 (en) 1997-11-06
ATE204760T1 (de) 2001-09-15
DE69428112T2 (de) 2002-03-21
EP0687181A1 (en) 1995-12-20
GR3037021T3 (en) 2002-01-31
PT687181E (pt) 2002-01-30
FI954127A0 (fi) 1995-09-04
MY121198A (en) 2006-01-28
NO953473L (no) 1995-09-04
WO1994020131A1 (en) 1994-09-15
NO320877B1 (no) 2006-02-06
NO953473D0 (no) 1995-09-04
CA2157479C (en) 2000-08-08
FI954127A (fi) 1995-09-04
CN1092322A (zh) 1994-09-21
CA2157479A1 (en) 1994-09-15
KR960700741A (ko) 1996-02-24
DK0687181T3 (da) 2001-10-01
KR100306024B1 (ko) 2001-11-30
EP0687181B1 (en) 2001-08-29
SG64894A1 (en) 1999-05-25
AU6275994A (en) 1994-09-26
JPH06279309A (ja) 1994-10-04

Similar Documents

Publication Publication Date Title
AU3216695A (en) Lipid analogs for treating viral infections
SE9602931L (sv) Ny medicinsk användning
DE68906735D1 (de) Pharmazeutische zubereitung zur behandlung von viruskrankheiten mit leber-extrakt.
DE60237721D1 (de) Kombinationstherapie mit omega-interferon zur behandlung von hepatitis c virus oder gelbfieber virus infektionen
EP0616535A4 (en) PROCESS FOR THE TREATMENT OF VIRAL INFECTIONS.
ES2162862T3 (es) Uso de la timosina para tratar la hepatitis c en pacientes que no responden al tratamiento con interferon.
ATE136468T1 (de) Impfstoff zur behandlung von hsv
ES2036526T3 (es) Composiciones de interferon.
ES2055314T3 (es) Tratamiento de disfuncion leucocitaria con gm-csf.
DK0531341T3 (da) Anvendelse af leukoregulin til behandling af dyr, der er inficeret med et kappevirus
EA200300222A1 (ru) Лечение гепатита c с помощью тимозина, интерферона и рибавирина
EP1143981A4 (en) TREATMENT AND PREVENTION OF HIV AND OTHER VIRUS INFECTIONS
MY101495A (en) Treatment of diseases caused by viruses
DE60121449D1 (de) Behandlung von hepatitis c mit thymosin und pegyliertem interferon
UA7180C2 (uk) Препарат для лікування та профілактики атерогенних дисліпопротеїнемій та синдрому гіперкоагуляції
MX9400210A (es) Tratamiento de infecciones virales.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 687181

Country of ref document: ES